Fundz
New|Fundz now works inside Claude2 min

Discover more near‑term opportunities with better event intelligence.

Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Terumo Neuro to acquire Arsenal Medical for innovation

PRIVATESep 30, 2026

Acquiring Company

Terumo Neuro

Acquired Company

Arsenal Medical

CaliforniaWatertownManufacturingBiotechnologyHealth CareMedicalmedical devicesBiotechnology

Description

Terumo Neuro has signed an agreement to acquire Arsenal Medical Inc. This acquisition will include NeoCast™, a new liquid embolic technology aimed at treating chronic subdural hematoma. The move is intended to strengthen Terumo Neuro's neurovascular portfolio and innovation strategy.

Company Information

Company

Terumo Neuro

Location

35 Enterprise

California, United States

About

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, the company focuses on creating innovative solutions that advance physician practice and improve patient outcomes. Their products are sold in over seventy countries through direct sales and strategic distribution partnerships.

Fundz sees it the moment Terumo Neuro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Terumo Neuro's next move

Learn about Strategic plan

Frequently asked

Who acquired Arsenal Medical?

Arsenal Medical was acquired by Terumo Neuro, based in California. The deal was reported on September 30, 2026. Terumo Neuro is privately held and operates in Manufacturing.

When did Terumo Neuro acquire Arsenal Medical?

Terumo Neuro's acquisition of Arsenal Medical was reported on September 30, 2026. Terumo Neuro has signed an agreement to acquire Arsenal Medical Inc. This acquisition will include NeoCast™, a new liquid embolic technology aimed at treating chronic subdural hematoma. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Arsenal Medical do?

Arsenal Medical Inc. is a privately held, clinical-stage biomaterials company. They focus on the development of innovative medical technologies, particularly in liquid embolic therapies. It is privately held, operating in Biotechnology, and is based in Watertown.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.